All In Biotech

Drug Trial Radar · NCT07361354

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of AGA2118 in Healthy Japanese, Chinese, and Caucasian Participants

Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

28

Actual

Start

Jan 5, 2026

Primary completion

Sep 5, 2026

Study completion Sep 5, 2026

Sponsor

Lead sponsor
Angitia Incorporated LimitedIndustry
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants

Conditions

  • Healthy Participants
  • Pharmacokinetic Study

Interventions

  • AGA2118Drug

    Participants will receive AGA2118 administered by subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum concentration (Cmax)Time frame: Day 1 to up to the end of study (85 days post-dose)
  2. Time to maximum concentration (Tmax)Time frame: Day 1 to up to the end of study (85 days post-dose)
  3. Area under the concentration-time curve (AUC)Time frame: Day 1 to up to the end of study (85 days post-dose)
  4. Half-life (t1/2)Time frame: Day 1 to up to the end of study (85 days post-dose)
  5. Clearance (CL)Time frame: Day 1 to up to the end of study (85 days post-dose)
  6. Volume of distribution (Vd)Time frame: Day 1 to up to the end of study (85 days post-dose)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Los Angeles EPCU

    Glendale, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.